Suspension of fertility treatment during the COVID-19 pandemic: views, emotional reactions and psychological distress among women undergoing fertility treatment.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
04 2021
Historique:
received: 01 09 2020
revised: 23 12 2020
accepted: 12 01 2021
pubmed: 10 2 2021
medline: 24 4 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

What are the views and emotional reactions of patients towards the suspension of fertility treatment during the COVID-19 pandemic, and what are the factors affecting their psychological distress? A cross-sectional study conducted in an academic fertility centre. Online questionnaires were distributed between 18 April 2020 and 23 April 2020 to patients whose treatment cycle had been postponed or discontinued. The outcome measures included agreement with the reproductive society guidelines to postpone treatments; willingness to resume treatments, given the choice; patients' emotional reactions; and psychological distress level, measured by the Mental Health Inventory validated scale. A multivariate linear regression was conducted to identify factors associated with psychological distress. Because of the small number of male respondents, only women were included in the analysis (n = 181). Forty-three per cent expressed disagreement with the guidelines and 82% were willing to resume treatments, given the choice. Sadness and anxiety were the most common emotional reactions expressed towards the guidelines. In the multivariate analysis, COVID-19-related anxiety (B = 0.145, P = 0.04) and disagreement with treatment suspension (B = -0.44, P = 0.001) were found to be significantly associated with patients' psychological distress. Background characteristics of patients did not contribute significantly to their distress. Suspension of fertility treatment during the initial phase of the COVID-19 pandemic was associated with patients' negative emotional reactions. Anxiety related to COVID-19 and disagreement with treatment suspension were found to be significantly associated with psychological distress among women undergoing fertility treatment, regardless of their background characteristics. Our findings suggest the need to monitor the mental health of patients and provide psychological support should a shutdown of fertility care re-occur.

Identifiants

pubmed: 33558171
pii: S1472-6483(21)00035-3
doi: 10.1016/j.rbmo.2021.01.007
pmc: PMC7816616
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-858

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Lilach Marom Haham (L)

CReATe Fertility Centre, Toronto, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.

Michal Youngster (M)

IVF Unit, Department of Obstetrics & Gynecology, Shamir Medical Center, Zerifin, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Adi Kuperman Shani (A)

CReATe Fertility Centre, Toronto, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.

Samantha Yee (S)

CReATe Fertility Centre, Toronto, Canada.

Reut Ben-Kimhy (R)

IVF Unit, Department of Obstetrics & Gynecology, Meir (Sapir) Medical Center, Kfar-Saba, Israel; The Gender Studies Program, Bar-Ilan University, Ramat Gan, Israel.

Tamar R Medina-Artom (TR)

Smokler Center for Health Policy Research, Myers-JDC-Brookdale Institute Jerusalem, Israel; The Bob Shapell School of Social Work, Tel Aviv University, Tel Aviv, Israel.

Ariel Hourvitz (A)

IVF Unit, Department of Obstetrics & Gynecology, Shamir Medical Center, Zerifin, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Alon Kedem (A)

IVF Unit, Department of Obstetrics & Gynecology, Shamir Medical Center, Zerifin, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Clifford Librach (C)

CReATe Fertility Centre, Toronto, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Canada; Department of Physiology, University of Toronto, Toronto, Canada. Electronic address: drlibrach@createivf.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH